Tg Therapeutics (TGTX) Revenue (2016 - 2025)
Historic Revenue for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $161.7 million.
- Tg Therapeutics' Revenue rose 9278.84% to $161.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $531.9 million, marking a year-over-year increase of 10087.54%. This contributed to the annual value of $329.0 million for FY2024, which is 4080.34% up from last year.
- As of Q3 2025, Tg Therapeutics' Revenue stood at $161.7 million, which was up 9278.84% from $141.1 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Revenue registered a high of $165.8 million during Q3 2023, and its lowest value of $80000.0 during Q4 2022.
- Over the past 5 years, Tg Therapeutics' median Revenue value was $16.1 million (recorded in 2023), while the average stood at $52.4 million.
- Its Revenue has fluctuated over the past 5 years, first crashed by 9655.32% in 2022, then skyrocketed by 17629893.62% in 2023.
- Tg Therapeutics' Revenue (Quarter) stood at $2.3 million in 2021, then plummeted by 96.55% to $80000.0 in 2022, then soared by 54863.75% to $44.0 million in 2023, then surged by 146.04% to $108.2 million in 2024, then skyrocketed by 49.47% to $161.7 million in 2025.
- Its Revenue was $161.7 million in Q3 2025, compared to $141.1 million in Q2 2025 and $120.9 million in Q1 2025.